Advertisement

Postexposure Prophylaxis in HIV

  • Pranav Sood
  • Shivani Sood
Chapter

Abstract

ARV drugs are in use since the last three decades for postexposure prophylaxis following occupational exposure to HIV, but more recently, the same has been extended to accidental exposure like unprotected intercourse, sexual assault, needle prick injuries, IV drug users, etc. Use of ART for postexposure prophylaxis is supported by animal studies [1], a case control study [2], and systematic reviews which have demonstrated reduced risk of acquiring chronic infection and cost-effectiveness in high-risk groups [3, 4]. That ARV drugs are effective in postexposure prophylaxis is further supported by their role in preexposure prophylaxis and in preventing mother-to-child transmission.

References

  1. 1.
    Corbett EL, et al. Uptake of workplace HIV counseling and testing: a cluster-randomized trial in Zimbabwe. PLoS Med. 2006;e238:3.Google Scholar
  2. 2.
    Grabbe KL, et al. Increasing access to HIV counseling and testing through mobile services in Kenya: strategies, utilization, and cost-effectiveness. J Acquir Immune Defic Syndr. 2010;54:317–23.CrossRefGoogle Scholar
  3. 3.
    Granich R, et al. Achieving universal access for human immunodeficiency virus and tuberculosis: potential prevention impact of an integrated multi-disease prevention campaign in Kenya. AIDS Res Treatment. 2012;2012:412643.CrossRefGoogle Scholar
  4. 4.
    Lugada E, et al. Comparison of home and clinic-based HIV testing among household members of persons taking antiretroviral therapy in Uganda: results from a randomized trial. J Acquir Immune Defic Syndr. 2010;55:245–52.CrossRefGoogle Scholar
  5. 5.
    Menzies N, et al. The costs and effectiveness of four HIV counseling and testing strategies in Uganda. AIDS. 2009;23:395–401.CrossRefGoogle Scholar
  6. 6.
    van Schaik N, et al. Earlier HIV diagnosis – are mobile services the answer? S Afr Med J. 2010;100:671–4.CrossRefGoogle Scholar
  7. 7.
    Chirawu P, et al. Acceptability and challenges of implementing voluntary counseling and testing (VCT) in rural Zimbabwe: evidence from the Regai Dzive Shiri Project. AIDS Care. 2010;22:81–8.CrossRefGoogle Scholar
  8. 8.
    Sweat M, et al. Community-based intervention to increase HIV testing and case detection in people aged 16-32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomized study. Lancet Infect Dis. 2011;11:525–32.CrossRefGoogle Scholar
  9. 9.
    Outlaw AY, et al. Using motivational interviewing in HIV field outreach with young African American men who have sex with men: a randomized clinical trial. Am J Public Health. 2010;100(Suppl. 1):S146–51.CrossRefGoogle Scholar
  10. 10.
    Prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and transgender people: recommendations for a public health approach. Geneva: World Health Organization; 2011. http://whqlibdoc.who.int/publications/2011/9789241501750_eng.pdf. Accessed 15 May 2013.
  11. 11.
    Delivering HIV test results and messages for re-testing and counseling in adults. Geneva: World Health Organization; 2010. http://whqlibdoc.who.int/publications/2010/9789241599115_eng.pdf. Accessed 15 May 2013.
  12. 12.
    Planning, implementing and monitoring home-based HIV testing. Geneva: World Health Organization; 2012. http://apps.who.int/iris/bitstream/10665/75366/1/9789241504317_eng.pdf. Accessed 15 May 2013.
  13. 13.
    Baeten JM, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410.CrossRefGoogle Scholar
  14. 14.
    Grant R, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.CrossRefGoogle Scholar
  15. 15.
    Thigpen MC, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423–34.CrossRefGoogle Scholar
  16. 16.
    Choopanya K, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomized, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381(9883):2083–90.CrossRefGoogle Scholar
  17. 17.
    Guidance on oral pre-exposure prophylaxis (PrEP) for sero discordant couples, men and transgender women who have sex with men at high risk of HIV: recommendations for use in the context of demonstration projects. Geneva: World Health Organization; 2012. http://apps.who.int/iris/bitstream/10665/75188/1/9789241503884_eng.pdf. Accessed 15 May 2013.
  18. 18.
    Ansara DL, Hindin MJ. Formal and informal help-seeking associated with women’s and men’s experiences of intimate partner violence in Canada. Soc Sci Med. 2010;70:1011–8.CrossRefGoogle Scholar
  19. 19.
    Weller SC, Davis-Beaty K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev. 2009;1:CD003255.Google Scholar
  20. 20.
    French PP, et al. Use-effectiveness of the female versus male condom in preventing sexually transmitted disease in women. Sex Transm Dis. 2003;30:433–9.CrossRefGoogle Scholar
  21. 21.
    Frank AP, et al. Anonymous HIV testing using home collection and telemedicine counseling. A multicenter evaluation. Arch Intern Med. 1997;157:309–14.CrossRefGoogle Scholar
  22. 22.
    Effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among IDUs. Geneva: World Health Organization; 2004. www.who.int/hiv/pub/idu/e4a-needle/en/index.html. Accessed 15 May 2013.
  23. 23.
    Effectiveness of drug dependence treatment in preventing HIV among injecting drug users. Geneva: World Health Organization; 2003. www.who.int/entity/hiv/pub/idu/drugdependencefinaldraft.pdf. Accessed 15 May 2013.
  24. 24.
    Konopnicki D, et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS. 2005;19:593–601.CrossRefGoogle Scholar
  25. 25.
    Puoti M, et al. Mortality for liver disease in patients with HIV infection: a cohort study. J Acquir Immune Defic Syndr. 2000;2:211–7.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  • Pranav Sood
    • 1
  • Shivani Sood
    • 1
  1. 1.Kamala Nehru HospitalShimlaIndia

Personalised recommendations